1. Home
  2. NTRA vs BNTX Comparison

NTRA vs BNTX Comparison

Compare NTRA & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$229.36

Market Cap

27.0B

Sector

Health Care

ML Signal

HOLD

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$95.02

Market Cap

24.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
BNTX
Founded
2003
2008
Country
United States
Germany
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.0B
24.8B
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
NTRA
BNTX
Price
$229.36
$95.02
Analyst Decision
Strong Buy
Buy
Analyst Count
15
11
Target Price
$238.20
$137.40
AVG Volume (30 Days)
1.2M
1.5M
Earning Date
11-06-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,116,676,000.00
$3,698,814,972.00
Revenue This Year
$33.18
$2.03
Revenue Next Year
$16.81
N/A
P/E Ratio
N/A
N/A
Revenue Growth
38.17
3.70
52 Week Low
$125.38
$81.20
52 Week High
$246.90
$129.27

Technical Indicators

Market Signals
Indicator
NTRA
BNTX
Relative Strength Index (RSI) 52.01 45.84
Support Level $227.89 $94.00
Resistance Level $237.04 $95.71
Average True Range (ATR) 5.07 1.74
MACD -1.57 0.52
Stochastic Oscillator 49.47 62.66

Price Performance

Historical Comparison
NTRA
BNTX

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: